Kingdon Capital Management’s Celgene Corp CELG Stock Holding History

Kingdon Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-254,244	Closed	-$24M	–	91
2019 Q1	$24M	Buy	+254,244	New	+$22.2M	3.21%	11
2014 Q3	–	Sell	-65,200	Closed	-$5.6M	–	216
2014 Q2	$5.6M	Buy	+65,200	New	+$4.96M	0.21%	121
2013 Q4	–	Sell	-31,152	Closed	-$2.4M	–	245
2013 Q3	$2.4M	Buy	+31,152	New	+$2.18M	0.12%	153

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Kingdon Capital Management's CELG Position: Q2 2019 in Review

Kingdon Capital Management sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 254,244 shares — an estimated $24M sold.

Kingdon Capital Management first reported a position in CELG in Q3 2013 and held it in 3 quarters. The position peaked at $24M in Q1 2019. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

Kingdon Capital Management reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
Kingdon Capital Management sold 254,244 Celgene Corp shares in Q2 2019, an estimated $24M.
Kingdon Capital Management first reported a position in Celgene Corp in Q3 2013 and held it in 3 quarters.
Kingdon Capital Management's Celgene Corp position peaked at $24M in Q1 2019.
1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Kingdon Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.